Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights
- PMID: 20113312
- DOI: 10.1042/BJ20091888
Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights
Abstract
To assess the potential of mutations from the L1 loop of the tumour suppressor p53 as second-site suppressors, the effect of H115N and S116M on the p53 'hot spot' mutations has been investigated using the double-mutant approach. The effects of these two mutants on the p53 hot spots in terms of thermal stability and DNA binding were evaluated. The results show that: (i) the p53 mutants H115N and S116M are thermally more stable than wild-type p53; (ii) H115N but not S116M is capable of rescuing the DNA binding of one of the most frequent p53 mutants in cancer, R248Q, as shown by binding of R248Q/H115N to gadd45 (the promoter of a gene involved in cell-cycle arrest); (iii) the double mutant R248Q/H115N is more stable than wild-type p53; (iv) the effect of H115N as a second-site suppressor to restore DNA-binding activity is specific to R248Q, but not to R248W; (v) molecular-dynamics simulations indicate that R248Q/H115N has a conformation similar to wild-type p53, which is distinct from that of R248Q. These findings could be exploited in designing strategies for cancer therapy to identify molecules that could mimic the effect of H115N in restoring function to oncogenic p53 mutants.
Similar articles
-
Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.J Mol Biol. 2009 Jan 9;385(1):249-65. doi: 10.1016/j.jmb.2008.10.063. Epub 2008 Oct 30. J Mol Biol. 2009. PMID: 18996393
-
In the quest for stable rescuing mutants of p53: computational mutagenesis of flexible loop L1.Biochemistry. 2005 Feb 8;44(5):1423-32. doi: 10.1021/bi047845y. Biochemistry. 2005. PMID: 15683227
-
In vitro analysis of the dominant negative effect of p53 mutants.J Mol Biol. 1998 Aug 14;281(2):205-9. doi: 10.1006/jmbi.1998.1897. J Mol Biol. 1998. PMID: 9698540
-
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.Cancer Res. 2000 Dec 15;60(24):6788-93. Cancer Res. 2000. PMID: 11156366 Review.
-
[Relevance of p53 protein and its mutations for novel strategies in cancer therapy].Cas Lek Cesk. 2004;143(5):313-7. Cas Lek Cesk. 2004. PMID: 15305766 Review. Czech.
Cited by
-
Rescue of deleterious mutations by the compensatory Y30F mutation in ketosteroid isomerase.Mol Cells. 2013 Jul;36(1):39-46. doi: 10.1007/s10059-013-0013-1. Epub 2013 Jun 3. Mol Cells. 2013. PMID: 23740430 Free PMC article.
-
Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells.Oncogene. 2016 Apr 28;35(17):2178-85. doi: 10.1038/onc.2015.278. Epub 2015 Aug 10. Oncogene. 2016. PMID: 26257058 Free PMC article.
-
Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain.Biochemistry. 2011 Jun 14;50(23):5345-53. doi: 10.1021/bi200192j. Epub 2011 May 17. Biochemistry. 2011. PMID: 21561095 Free PMC article.
-
Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket.Nucleic Acids Res. 2019 Feb 28;47(4):1637-1652. doi: 10.1093/nar/gky1314. Nucleic Acids Res. 2019. PMID: 30649466 Free PMC article.
-
In silico identification of rescue sites by double force scanning.Bioinformatics. 2018 Jan 15;34(2):207-214. doi: 10.1093/bioinformatics/btx515. Bioinformatics. 2018. PMID: 28961796 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous